GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor for Oxidative Stress Research

Executive Summary: GKT137831 is a highly selective inhibitor of NADPH oxidase isoforms Nox1 (Ki: 140 nM) and Nox4 (Ki: 110 nM), enabling targeted attenuation of reactive oxygen species (ROS) in preclinical and translational models (APExBIO). It modulates key redox-dependent pathways including Akt/mTOR and NF-κB, impacting processes such as inflammation, fibrosis, and cell proliferation (Yang et al., 2025). In vitro, it inhibits hypoxia-induced H2O2 release and suppresses proliferation of vascular cells. In vivo, oral GKT137831 (30–60 mg/kg/day) reduces pulmonary vascular remodeling, liver fibrosis, and diabetes-accelerated atherosclerosis. These effects are robustly documented at defined concentrations and conditions, supporting the reagent's use in oxidative stress research and therapeutic development (Related Review).

Biological Rationale

NADPH oxidase (NOX) enzymes are critical sources of cellular reactive oxygen species (ROS) in mammalian tissues. Nox1 and Nox4 isoforms are upregulated in diverse pathologies, including pulmonary hypertension, liver fibrosis, and diabetes-accelerated atherosclerosis (Yang et al., 2025). ROS produced by these isoforms mediate oxidative stress, driving inflammation, tissue remodeling, and fibrotic responses. Modulation of NOX-derived ROS enables researchers to dissect redox-sensitive disease mechanisms and evaluate therapeutic interventions. GKT137831, provided by APExBIO, delivers high selectivity for Nox1 and Nox4, distinguishing it from broad-spectrum antioxidants or non-specific inhibitors (GKT137831 product page).

Mechanism of Action of GKT137831

GKT137831 directly binds to and inhibits the catalytic subunits of Nox1 and Nox4. The inhibitory constants are 140 nM for Nox1 and 110 nM for Nox4, determined under standard in vitro assay conditions (25°C, pH 7.4, 30 min) (APExBIO). This inhibition reduces the conversion of NADPH to superoxide (O₂^•−) and downstream hydrogen peroxide (H₂O₂). Lowered ROS levels modulate signaling pathways such as Akt/mTOR, which governs cell growth and metabolism, and NF-κB, a central regulator of inflammation. In cell-based assays, GKT137831 attenuates hypoxia-induced H₂O₂ release and decreases proliferation of human pulmonary artery endothelial and smooth muscle cells. It also downregulates expression of TGF-β1, a profibrotic cytokine, and upregulates PPARγ, which opposes fibrotic signaling (Strategic Dual Nox1/Nox4 Inhibition). This mechanistic profile distinguishes GKT137831 from agents that target downstream ROS effects or general redox systems.

Evidence & Benchmarks

• In vitro, GKT137831 (0.1–20 μM, 24 h, 37°C) inhibits hypoxia-induced H₂O₂ release in human pulmonary artery endothelial cells (HPAECs) and smooth muscle cells (HPASMCs) (APExBIO).
• GKT137831 reduces proliferation of vascular cells in response to hypoxia and growth factors (10 μM, 24 h) (APExBIO).
• In vivo, oral administration of GKT137831 (30–60 mg/kg/day, 28 days) attenuates chronic hypoxia-induced pulmonary vascular remodeling in mice (Yang et al., 2025).
• GKT137831 reduces liver fibrosis in mouse models (60 mg/kg/day, 6 weeks, oral) (Yang et al., 2025).
• It prevents diabetes mellitus-accelerated atherosclerosis in ApoE^−/− mice (60 mg/kg/day, 8 weeks) (Yang et al., 2025).
• Clinical studies support safety and pharmacodynamic effects in humans, with translational relevance for oxidative stress-related diseases (APExBIO).

This article extends the mechanistic focus of GKT137831: Mechanistic Insights and Next-Gen Applications by providing atomic, quantitative benchmarks and direct evidence links.

Applications, Limits & Misconceptions

GKT137831 is validated for research in fibrosis, pulmonary vascular remodeling, and atherosclerosis. It is used to dissect roles of Nox1/Nox4 in redox signaling, membrane biology, and cellular pathology (Redefining Translational Redox Biology). Its selectivity enables mechanistic studies without confounding off-target redox effects. However, GKT137831 is not a pan-NADPH oxidase inhibitor and does not target other ROS-generating systems such as mitochondrial complexes or myeloperoxidase.

Common Pitfalls or Misconceptions

• GKT137831 does not inhibit Nox2, Nox3, or Nox5 isoforms at recommended concentrations.
• It is ineffective against non-NADPH oxidase ROS sources (e.g., xanthine oxidase, mitochondria).
• Water insolubility may cause experimental artifacts if not fully dissolved in DMSO or ethanol.
• Long-term storage of GKT137831 solutions (>1 week) at room temperature leads to degradation and loss of activity.
• Not all models of oxidative stress are Nox1/Nox4-dependent; lack of effect may reflect pathway specificity, not compound failure.

Workflow Integration & Parameters

GKT137831 is supplied as a solid by APExBIO (SKU: B4763; product page). It is soluble at ≥39.5 mg/mL in DMSO and moderately soluble in ethanol (≥2.96 mg/mL with warming and sonication). The compound is insoluble in water. Standard storage is at −20°C. Recommended experimental concentrations are 0.1–20 μM for cell-based assays (incubation: 24 hours, 37°C, 5% CO₂). For in vivo studies in mice, oral dosing at 30–60 mg/kg/day has been validated for efficacy and safety. Researchers should avoid prolonged storage of prepared solutions and verify full dissolution before use. For additional context on integrating GKT137831 into redox research workflows and optimizing experimental design, see Strategically Advancing Redox Disease Research: GKT137831, which this article updates with the latest quantitative data and storage guidance.

Conclusion & Outlook

GKT137831 is a rigorously characterized, selective dual Nox1/Nox4 inhibitor that empowers researchers to interrogate oxidative stress mechanisms in disease models. Its well-defined mode of action, solubility, and dosing parameters support reproducible, mechanistic experiments. Ongoing clinical and translational studies will further delineate its therapeutic potential for fibrosis, vascular remodeling, and metabolic disease. For detailed protocols and ordering information, visit the GKT137831 product page.